Skip to main content

Entity contact

transpersonal effect

valencecontext-dependentfrequencyuncommontemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Entity contact is the perception of one or more seemingly autonomous beings during an altered state — figures, presences, or intelligences that appear to exist independently of the perceiver.

As a drug effect it is acute and strongly dose-dependent, arising almost exclusively at high doses and fading as the substance wears off. It ranges from a vague sense of unseen company to sustained, interactive encounters with beings of striking specificity and apparent agency.

Entity contact is uncommon relative to other perceptual effects but is among the most consistently reported phenomena at peak doses. It is most commonly induced at high doses under psychedelics such as DMT, psilocybin mushrooms, and LSD, and under dissociatives such as ketamine. It also appears under hallucinogens such as ibogaine, and has been reported in rare cases under depressants such as methaqualone.

phenomenology

Entity contact is felt as an encounter with presences that seem independent of imagination: they arrive with distinct character, intent, and often apparent awareness of the perceiver. Communication may feel wordless yet unambiguous.

The experience commonly comes with a profound sense of significance, a suspension of ordinary time, and a quality of physical stillness. Attending closely to an entity tends to make it more vivid and defined. At the highest doses, particularly under psychedelics, encounters can take on a quality of cosmic weight and urgent meaning.

mechanism

Entity contact arises through different pathways depending on the drug class:

  • Psychedelics — act on 5-HT2A receptors, radically disrupting the default mode network; at peak doses, autonomous percepts emerge from the breakdown of the brain's ordinary self-model.
  • Dissociatives — block NMDA receptors, severing sensory feedback and generating internally sourced perceptual worlds in which entities may appear.
  • Hallucinogens — ibogaine produces prolonged waking-dream states in which encounter experiences are frequently reported.
  • Depressants — reports under this class remain rare and the mechanism is poorly characterized.

How much each pathway contributes in a given case is not fully understood.

variability

Who experiences it, and how strongly, varies widely. It is almost exclusively a high-dose phenomenon; even with the most entity-associated substances, moderate doses rarely produce it.

Set and setting play an outsize role — especially under psychedelics and hallucinogens — and people who approach altered states with a framework that includes non-ordinary beings report it more often. Expectation is strongly self-fulfilling: going in with no concept of entity contact rarely produces it. Grounded, familiar surroundings reduce its likelihood without eliminating it.

practices

experience reports

No experience reports yet. Be the first to contribute.

First-person accounts of subjective effects, timing, and outcomes — submitted for harm reduction.

AI-generated · claude-sonnet-4-6 · reviewed

Harm-reduction reference — not medical advice.

Last updated May 25, 2026Report an issue